These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36174640)

  • 1. Faecal microbiota transplantation in patients with haematological malignancies undergoing cellular therapies: from translational research to routine clinical practice.
    Malard F; Gaugler B; Mohty M
    Lancet Haematol; 2022 Oct; 9(10):e776-e785. PubMed ID: 36174640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria.
    Battipaglia G; Malard F; Rubio MT; Ruggeri A; Mamez AC; Brissot E; Giannotti F; Dulery R; Joly AC; Baylatry MT; Kossmann MJ; Tankovic J; Beaugerie L; Sokol H; Mohty M
    Haematologica; 2019 Aug; 104(8):1682-1688. PubMed ID: 30733264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
    Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
    Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and acute graft-versus-host disease.
    Yoshioka K; Kakihana K; Doki N; Ohashi K
    Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
    Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
    Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells.
    Sanber K; Savani B; Jain T
    Br J Haematol; 2021 Dec; 195(5):660-668. PubMed ID: 34036558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease.
    Yue X; Zhou H; Wang S; Chen X; Xiao H
    Cancer Med; 2024 Feb; 13(3):e6799. PubMed ID: 38239049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms.
    Nguyen CL; Docampo MD; van den Brink MR; Markey KA
    Curr Opin Genet Dev; 2021 Feb; 66():25-35. PubMed ID: 33388483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in understanding the pathogenesis of graft-versus-host disease.
    Magenau J; Runaas L; Reddy P
    Br J Haematol; 2016 Apr; 173(2):190-205. PubMed ID: 27019012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fecal microbiota transplantation for acute graft-versus-host disease of the gut].
    Kakihana K
    Rinsho Ketsueki; 2017; 58(5):499-505. PubMed ID: 28592766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation.
    Fujiwara H
    Front Immunol; 2021; 12():703298. PubMed ID: 34512627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation.
    Ciernikova S; Kasperova B; Drgona L; Smolkova B; Stevurkova V; Mego M
    Blood Rev; 2021 Jul; 48():100790. PubMed ID: 33573867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation.
    DeFilipp Z; Hohmann E; Jenq RR; Chen YB
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):e17-e22. PubMed ID: 30408565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal microbiota transplantation for
    Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
    United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients.
    van Lier YF; Davids M; Haverkate NJE; de Groot PF; Donker ML; Meijer E; Heubel-Moenen FCJI; Nur E; Zeerleder SS; Nieuwdorp M; Blom B; Hazenberg MD
    Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32801142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting.
    Metafuni E; Di Marino L; Giammarco S; Bellesi S; Limongiello MA; Sorà F; Frioni F; Maggi R; Chiusolo P; Sica S
    Microorganisms; 2023 Aug; 11(9):. PubMed ID: 37764025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation.
    Dey BR; McAfee S; Colby C; Sackstein R; Saidman S; Tarbell N; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2003 May; 9(5):320-9. PubMed ID: 12766882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
    Penack O; Marchetti M; Ruutu T; Aljurf M; Bacigalupo A; Bonifazi F; Ciceri F; Cornelissen J; Malladi R; Duarte RF; Giebel S; Greinix H; Holler E; Lawitschka A; Mielke S; Mohty M; Arat M; Nagler A; Passweg J; Schoemans H; Socié G; Solano C; Vrhovac R; Zeiser R; Kröger N; Basak GW
    Lancet Haematol; 2020 Feb; 7(2):e157-e167. PubMed ID: 32004485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.